CD9 Antikörper
-
- Target Alle CD9 Antikörper anzeigen
- CD9
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CD9 Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS)
- Spezifität
- Human/Hamster/Canine/Feline/Monkey/Rabbit/Raccoon CD9, Mr 24 kDa
- Produktmerkmale
- Mouse Anti-Human CD9-UNLB
- Aufreinigung
- Purified
- Immunogen
- Unknown
- Klon
- MM2-57
- Isotyp
- IgG2b
- Top Product
- Discover our top product CD9 Primärantikörper
-
-
- Applikationshinweise
-
- Applications: FC - Quality tested , IHC-FS - Reported in literature , ICC - Reported in literature , IP - Reported in literature , WB - Reported in literature
- Working Dilutions: Flow Cytometry Purified (UNLB) antibody 1 g/106 cells FITC and PE conjugates 10 L/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L
- Kommentare
-
platelet inhibition and aggregation studies
- Probenmenge
- 1 mL
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 0.1 mg/mL
- Buffer
- 0.1 mg of purified immunoglobulin in 1.0 mL of borate buffered saline, pH 8.2. No preservatives or amine-containing buffer salts added
- Konservierungsmittel
- Without preservative
- Handhabung
- Each reagent is stable for the period shown on the bottle label if stored as directed.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Store at 2-8°C
-
-
Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: a novel antiangiogenic therapy." in: Biochemical and biophysical research communications, Vol. 413, Issue 1, pp. 128-35, (2011) (PubMed).
: "
-
Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: a novel antiangiogenic therapy." in: Biochemical and biophysical research communications, Vol. 413, Issue 1, pp. 128-35, (2011) (PubMed).
-
- Target
- CD9
- Andere Bezeichnung
- CD9 (CD9 Produkte)
- Synonyme
- BTCC-1 antikoerper, DRAP-27 antikoerper, MIC3 antikoerper, MRP-1 antikoerper, TSPAN-29 antikoerper, TSPAN29 antikoerper, Tspan29 antikoerper, cd9 antikoerper, wu:fb61g04 antikoerper, zgc:73383 antikoerper, zgc:85743 antikoerper, CD9 molecule antikoerper, CD9 antigen antikoerper, CD9 molecule a antikoerper, CD9 antikoerper, Cd9 antikoerper, cd9a antikoerper
- Hintergrund
- CD9 is a 24 kDa member of the transmembrane 4 superfamily (TM4-SF) of cell surface receptors. It is expressed strongly on platelets, lymphoid progenitor cells, activated lymphocytes and endothelia, and, weakly, on eosinophils, granulocytes, monocytes, and macrophages. CD9 functions as an adhesion molecule where it mediates platelet aggregation and activation.
- Pathways
- Response to Water Deprivation, Cell-Cell Junction Organization
-